Praxis Precision Medicines, Inc. PRAX Weighted Average Exercise Price of Vested and Expected to Vest Options
Weighted Average Exercise Price of Vested and Expected to Vest Options at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s weighted average exercise price of vested and expected to vest options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s weighted average exercise price of vested and expected to vest options?
- Praxis Precision Medicines, Inc. (PRAX) reported weighted average exercise price of vested and expected to vest options of $101.08 in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s weighted average exercise price of vested and expected to vest options changed year-over-year?
- Praxis Precision Medicines, Inc.'s weighted average exercise price of vested and expected to vest options increased by 15.1% year-over-year, from $87.82 to $101.08.